Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 120,376 |
|
|||||
| News | - | ||||||
| Day High | 3.6556 | Low High |
|||||
| Day Low | 3.2071 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tharimmune Inc | THAR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.01 | 0.30% | 3.35 | 00:00:03 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.25 | 3.2071 | 3.6556 | 3.35 | 3.34 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,734 | 120,376 | $ 3.46 | $ 416,695 | - | 2.75 - 142.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:52:58 | 20 | $ 3.44 | USD |
Tharimmune Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 39.33M | 11.74M | - | 0 | -9.32M | -0.79 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Tharimmune News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical THAR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.10 | 5.255 | 2.75 | 3.46 | 106,237 | -1.75 | -34.31% |
| 1 Month | 5.49 | 6.00 | 2.75 | 4.77 | 241,613 | -2.14 | -38.98% |
| 3 Months | 6.75 | 7.461 | 2.75 | 5.65 | 226,471 | -3.40 | -50.37% |
| 6 Months | 7.065 | 8.55 | 2.75 | 6.59 | 496,612 | -3.72 | -52.58% |
| 1 Year | 82.50 | 142.50 | 2.75 | 55.42 | 1,265,612 | -79.15 | -95.94% |
| 3 Years | 82.50 | 142.50 | 2.75 | 55.42 | 1,265,612 | -79.15 | -95.94% |
| 5 Years | 82.50 | 142.50 | 2.75 | 55.42 | 1,265,612 | -79.15 | -95.94% |
Tharimmune Description
| Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death for drug-resistant and devastating cancers. |
